HOLX - Hologic, Inc.
NASDAQ
->
Healthcare
->
Medical Instruments & Supplies
Marlborough,
United States
Type: Equity
HOLX price evolution
HOLX
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1932.1 | $2722.5 | $2765 | $2582.2 |
| Short term investments | ||||
| Net receivables | $670.9 | $625.6 | $686.8 | $714 |
| Inventory | $633.6 | $617.6 | $680.1 | $687.6 |
| Total current assets | $3494.2 | $4184.5 | $4339.3 | $4211.4 |
| Long term investments | ||||
| Property, plant & equipment | $527 | $517 | $493.3 | $497.9 |
| Goodwill & intangible assets | $4138.6 | $4169.9 | $4238.3 | $4499.1 |
| Total noncurrent assets | $4975.3 | $4954.8 | $4998.6 | $5237.3 |
| Total investments | ||||
| Total assets | $8469.5 | $9139.3 | $9337.9 | $9448.7 |
| Current liabilities | ||||
| Accounts payable | $183.8 | $712.9 | $180.6 | $187.4 |
| Deferred revenue | $204.8 | $213 | $246.6 | $243.3 |
| Short long term debt | $40.6 | $290.1 | $34.7 | $29.1 |
| Total current liabilities | $899 | $1207.3 | $981.3 | $955 |
| Long term debt | $2537.4 | $2531.2 | $2805.5 | $2814.7 |
| Total noncurrent liabilities | $2916.7 | $2915.1 | $3174.6 | $3192.9 |
| Total debt | $2578 | $2836.6 | $2840.2 | $2843.8 |
| Total liabilities | $3815.7 | $4122.4 | $4155.9 | $4147.9 |
| Shareholders' equity | ||||
| Retained earnings | $2302.8 | $2056.3 | $1965.7 | $2006.2 |
| Other shareholder equity | -$118.8 | $5016.9 | -$113.6 | -$118.4 |
| Total shareholder equity | $4653.8 | $5016.9 | $5182 | $5300.8 |
| (in millions $) | 30 Oct 2023 | 24 Oct 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2722.5 | $2339.5 | $1170.3 | $701 |
| Short term investments | ||||
| Net receivables | $625.6 | $617.6 | $942.7 | $1028.9 |
| Inventory | $617.6 | $623.7 | $501.2 | $395.1 |
| Total current assets | $4184.5 | $3862 | $3168.7 | $2222.3 |
| Long term investments | $11.4 | |||
| Property, plant & equipment | $517 | $481.6 | $564.7 | $491.5 |
| Goodwill & intangible assets | $4169.9 | $4517.1 | $4940.8 | $3965.4 |
| Total noncurrent assets | $4954.8 | $5209.2 | $5751.2 | $4973.5 |
| Total investments | ||||
| Total assets | $9139.3 | $9071.2 | $8919.9 | $7195.8 |
| Current liabilities | ||||
| Accounts payable | $712.9 | $197.7 | $215.9 | $178.8 |
| Deferred revenue | $213 | $195.9 | $218.3 | $199 |
| Short long term debt | $290.1 | $18.2 | $316.7 | $326.8 |
| Total current liabilities | $1207.3 | $937.7 | $1326.8 | $1239.3 |
| Long term debt | $2531.2 | $2808.4 | $2735 | $2731.3 |
| Total noncurrent liabilities | $2915.1 | $3257.3 | $3374.5 | $3249.2 |
| Total debt | $2836.6 | $2844.6 | $3051.7 | $3058.1 |
| Total liabilities | $4122.4 | $4195 | $4701.3 | $4488.5 |
| Shareholders' equity | ||||
| Retained earnings | $2056.3 | $1600.3 | $298.3 | -$1573.2 |
| Other shareholder equity | $5016.9 | $4876.2 | -$59.1 | -$49.7 |
| Total shareholder equity | $5016.9 | $4876.2 | $4218.6 | $2705.2 |
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jul 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1013.1 | $945.3 | $1026.5 | |
| Cost of revenue | $445.6 | $440.7 | ||
| Gross Profit | $567.5 | $500.3 | $585.8 | |
| Operating activities | ||||
| Research & development | $66.8 | $74 | ||
| Selling, general & administrative | $260.7 | $243.2 | ||
| Total operating expenses | $367.6 | $311.5 | $326.1 | |
| Operating income | $199.9 | $259.7 | ||
| Income from continuing operations | ||||
| EBIT | $217.3 | $306.5 | ||
| Income tax expense | -$55.2 | $55 | $60.8 | |
| Interest expense | $26 | $10.3 | $27.2 | |
| Net income | ||||
| Net income | $246.5 | $90.6 | $218.5 | |
| Income (for common shares) | $246.5 | $218.5 | ||
| (in millions $) | 30 Oct 2023 | 24 Oct 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4030.4 | $4862.8 | $3776.4 | |
| Cost of revenue | $1548.9 | |||
| Gross Profit | $2251 | $3014.8 | $2227.5 | |
| Operating activities | ||||
| Research & development | $222.5 | |||
| Selling, general & administrative | $840.6 | |||
| Total operating expenses | $1310 | $1366.6 | $1122.5 | |
| Operating income | $1105 | |||
| Income from continuing operations | ||||
| EBIT | $1123.1 | |||
| Income tax expense | $220.1 | $286.2 | -$108.6 | |
| Interest expense | $24.3 | -$42.7 | $116.5 | |
| Net income | ||||
| Net income | $456 | $1302 | $1115.2 | |
| Income (for common shares) | $1115.2 | |||
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $246.5 | -$40.5 | $218.5 | |
| Operating activities | ||||
| Depreciation | $88.4 | $81.2 | $80.8 | |
| Business acquisitions & disposals | -$31.3 | -$1.8 | ||
| Stock-based compensation | $28.7 | $16.9 | $23.2 | |
| Total cash flows from operations | $220 | $332.8 | $206.3 | |
| Investing activities | ||||
| Capital expenditures | -$38 | -$36.5 | -$32.1 | |
| Investments | -$34.5 | |||
| Total cash flows from investing | -$104.2 | -$152.1 | -$38.7 | -$16.4 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$667.3 | -$104.3 | -$36.7 | |
| Net borrowings | -$260.3 | -$4.8 | -$5 | |
| Total cash flows from financing | -$943.8 | -$483.2 | -$109.6 | -$49.5 |
| Effect of exchange rate | $4.4 | $0.3 | -$1.7 | $0.5 |
| Change in cash and equivalents | -$823.6 | $416.2 | $182.8 | $140.9 |
| (in millions $) | 30 Oct 2023 | 24 Oct 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $1871.5 | $1115.2 | ||
| Operating activities | ||||
| Depreciation | $406.9 | $376 | ||
| Business acquisitions & disposals | -$1164.7 | $19.9 | ||
| Stock-based compensation | $65 | $83.3 | ||
| Total cash flows from operations | $2330.4 | $896.6 | ||
| Investing activities | ||||
| Capital expenditures | -$162.7 | -$156.4 | ||
| Investments | ||||
| Total cash flows from investing | -$152.1 | -$206.3 | -$1329.6 | -$141.6 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$358.5 | -$588 | ||
| Net borrowings | -$113.4 | -$31.5 | ||
| Total cash flows from financing | -$483.2 | -$756 | -$529.8 | -$659.9 |
| Effect of exchange rate | $0.3 | $5.8 | -$1.7 | $4.1 |
| Change in cash and equivalents | $416.2 | $1169.2 | $469.3 | $99.2 |
News
Fundamentals
| Market cap | $17.88B |
|---|---|
| Enterprise value | $18.52B |
| Shares outstanding | 234.54M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | -5.69% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 3.75 |
| Book/Share | 20.35 |
| Cash/Share | 8.24 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.82 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.89 |
| Quick ratio | 3.18 |